We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

D&A PHARMA Presents 3 Major Clinical Studies at the 14th Congress of ESBRA

News   Sep 09, 2013

 
D&A PHARMA Presents 3 Major Clinical Studies at the 14th Congress of ESBRA
 
 
 

RELATED ARTICLES

Having a Heavier First-Born or Shorter Pregnancy May Increase Mother’s Breast Cancer Risk

News

Short first pregnancies and having a heavier first-born child may slightly increase a mother’s risk of breast cancer, a new study has found.

READ MORE

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

Paralysis from Rare Disorder: Stem Cell Therapy Trial Brings Hope

News

A clinical trial is planned to see if a single injection of progenitor cells can help repair spinal cords inflamed by transverse myelitis.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE